POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,111,700 | +153.1% | 467,101 | +87.1% | 0.00% | – |
| Q2 2023 | $439,282 | -51.4% | 249,592 | -14.9% | 0.00% | – |
| Q1 2023 | $903,555 | +32.5% | 293,362 | +127.9% | 0.00% | – |
| Q4 2022 | $682,179 | +160.4% | 128,713 | +73.6% | 0.00% | – |
| Q3 2022 | $262,000 | +125.9% | 74,144 | +65.8% | 0.00% | – |
| Q2 2022 | $116,000 | -54.2% | 44,715 | -20.8% | 0.00% | – |
| Q1 2022 | $253,000 | -52.4% | 56,477 | -27.5% | 0.00% | – |
| Q4 2021 | $531,000 | +27.6% | 77,932 | +36.3% | 0.00% | – |
| Q3 2021 | $416,000 | +20.6% | 57,175 | +65.9% | 0.00% | – |
| Q2 2021 | $345,000 | -8.0% | 34,457 | -12.2% | 0.00% | – |
| Q1 2021 | $375,000 | -18.7% | 39,249 | -6.6% | 0.00% | – |
| Q4 2020 | $461,000 | +43.2% | 42,025 | +15.9% | 0.00% | – |
| Q3 2020 | $322,000 | – | 36,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |